FDA Approval: Sexual Health in Aging Women Gains Recognition
Okay, here’s a breakdown of the citations provided, formatted for clarity:
1. FDA Grants Approval for Addyi (Flibanserin) in Postmenopausal Women. PRNewswire. Published December 19, 2023. accessed December 15, 2025. https://www.prnewswire.com/news-releases/historic-first-in-womens-sexual-health-fda-grants-approval-for-addyi-flibanserin-in-postmenopausal-women-302642397.html
2. Hypoactive Sexual Desire Disorder (HSDD). American Sexual Health Association. Accessed December 15, 2025. https://www.ashasexualhealth.org/hypoactive-sexual-desire-disorder/
3. Low sex drive - could it be a sign of depression? John Hopkins Medicine. Accessed December 15, 2025. (The URL is incomplete in the provided text,so I cannot include it.)
Key Observations:
* Access Date: All sources were accessed on December 15, 2025.
* Source Types: The sources include a press release (PRNewswire), a health association website (ASHA), and a medical institution’s website (John Hopkins Medicine).
* Topic: All citations relate to female sexual health, specifically low sexual desire and potential causes/treatments.
* Astro Islands: The text includes code related to ”astro-island,” which suggests this content is generated by or formatted for the Astro static site generator. This is not relevant to the citations themselves, but explains the extra code you see.
If you can provide the complete URL for citation #3, I can update the list accordingly.